MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Synucleinopathies"

  • 2023 International Congress

    Peripheral Synucleinopathy in Essential Tremor Plus Patients with Parkinsonian Features and Normal Dopamine Transporter Imaging

    VG. Evidente, T. Levine, D. Evidente, R. Freeman, C. Gibbons (Scottsdale, USA)

    Objective: To describe results of skin biopsy for phosphorylated alpha-synuclein (P-SYN) in patients with essential tremor (ET) with parkinsonism. Background: Patients with longstanding ET may…
  • 2023 International Congress

    In vivo proteomic investigation of deeply phenotyped parkinsonian syndromes for biomarkers of differential diagnosis

    S. Katzdobler, A. Bernhardt, G. Nübling, C. Palleis, U. Fietzek, E. Weidinger, M. Brendel, G. Höglinger, J. Levin (Munich, Germany)

    Objective: To investigate deeply-phenotyped cohorts of parkinsonian syndromes using proteomic technologies for identification of biomarkers for differential diagnosis Background: Proteomic technologies like Olink® Explore 3072…
  • 2023 International Congress

    Widespread Synuclein pathology in hyposmics precedes dopamine transporter deficit in PARS

    K. Marek, D. Russell, L. Concha, C. Caspell-Garcia, E. Brown, M. Brumm, C. Choi, M. Stern, D. Jennings, C. Soto, A. Siderowf (New Haven, USA)

    Objective: The Parkinson Associated Risk syndrome (PARS) study is designed to identify a Parkinson disease (PD) biomarker/clinical marker derived cohort enriched to develop typical symptoms…
  • 2023 International Congress

    Clinico-pathological correlations in atypical parkinsonism

    R. Fumi, M. Theilmann Jensen, L. Wu, D. Vaughan, V. Chelban, Y. Goh, R. Real, A. Martinez Carrasco, E. Jabbari, A. Church, J. Coebergh, C. Kobylecki, U. Nath, M. Hu, A. Misbahuddin, J. Sharma, L. Massey, E. Capps, A. Robinson, F. Roncaroli, A. Lees, O. Ansorge, K. Allison, T. Warner, J. Rohrer, T. Revesz, Z. Jaunmuktane, J. Rowe, H. Houlden, H. Morris (London, United Kingdom)

    Objective: We aim to assess diagnostic accuracy of the Parkinson-plus syndromes (PPS) using the current consensus criteria, whilst identifying the diagnostically most salient clinical features.…
  • 2023 International Congress

    Combined GWAS of Dementia with Lewy Bodies, REM-Sleep Behavior Disorder, Parkinson’s Disease and Alzheimer’s Disease

    P. Saini, E. Yu, L. Krohn, Z. Gan-Or (Montreal, Canada)

    Objective: To identify genetic variants that are either shared between or specific for Dementia with Lewy Bodies (DLB), REM Behavior Disorder (RBD), Parkinson’s disease (PD)…
  • 2022 International Congress

    The anti-alpha-synuclein antibody Lu AF82422 was safe and well tolerated in a FIH-SAD study in healthy subjects and patients with PD

    L. Buur, J. Wiedemann, F. Larsen, F. Ben Alaya-Fourati, P. Kallunki, D. Ditlevsen, M. Sørensen, D. Meulien (Valby, Denmark)

    Objective: Evaluation of safety, tolerability, pharmacokinetics (PK) and target engagement (TE) in healthy subjects (HS) and patients with Parkinson’s disease (PD) following single ascending doses…
  • 2022 International Congress

    Remote keyboard tapping: potential signatures of early motor dysfunction in isolated REM sleep behaviour disorder

    C. Simonet, L. Perez-Carbonell, H. Chohan, N. Akram, H. Li, A. Gill, J. Bestwick, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To compare keyboard tapping performance in people with iRBD with controls. Background: The Distal Finger Tapping (DFT)1 test and BRadykineisa Akinesia Incoordination test (BRAIN)2…
  • 2022 International Congress

    Differential proteomic analysis of plasma exosomes in Parkinson disease associated with mutations in the GBA gene

    T. Usenko, A. Bezrukova, K. Basharova, D. Kulabukhova, I. Miliukhina, E. Zakharova, S. Naryzhny, S. Pchelina (Gatchina, Russian Federation)

    Objective: To identify the protein changes and to search the potential biomarkers of PD among GBA mutation carriers. Background: Mutations in the GBA gene encoding glucocerebrosidase enzyme are the…
  • 2022 International Congress

    Intestinal microbial dysbiosis promotes prebiotic-reversible inflammation in Parkinson’s disease

    R. Manfready, D. Hall, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: To determine the functional effects of disrupted intestinal microbiota in Parkinson’s disease (PD), particularly the impacts of dysbiosis on inflammation, neuroprotective hormone secretion, and…
  • 2022 International Congress

    Prevalence and distribution of disease-associated alpha-synuclein in a homeless population

    N. Visanji, K. Danics, G. Kovacs (Toronto, Canada)

    Objective: To study the prevalence and distribution of pathological alpha-synuclein deposition, throughout the central and peripheral nervous systems, in a homeless population. Background: The homeless…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley